62
Participants
Start Date
May 11, 2018
Primary Completion Date
July 30, 2019
Study Completion Date
September 30, 2019
REL-1017
REL-1017 will be administered as an oral solution. Patients will continue to take the same, stabilized antidepressant medication that they were taking at screening throughout the course of the study.
Placebo
Placebo will be administered as an oral solution. Patients will continue to take the same, stabilized antidepressant medication that they were taking at screening throughout the course of the study.
iResearch Atlanta, LLC, Decatur
Atlanta Center for Medical Research, Atlanta
Innovative Clinical Research, Inc, Hialeah
St. Louis Clinical Trials, LLC, St Louis
Woodland International Research Group, Little Rock
Pillar Clinical Research, LLC, Richardson
Artemis Institute for Clinical Research, San Diego
Collaborative Neuroscience Network, LLC, Garden Grove
Hassman Research Institute, Berlin
Midwest Clinical Research Center, Dayton
Collaborators (1)
Syneos Health
OTHER
Relmada Therapeutics, Inc.
INDUSTRY